CEO of Beigene (30-Year Financial, Insider Trades) John Oyler (insider trades) sold 55,175 shares of BGNE on 07/21/2020 at an average price of $251.84 a share. The total sale was $13.9 million.
BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent. BeiGene Ltd has a market cap of $21.62 billion; its shares were traded at around $235.90 with and P/S ratio of 36.18. GuruFocus has detected 3 severe warning signs with BeiGene Ltd. .
CEO Recent Trades:
- CEO John Oyler sold 27,748 shares of BGNE stock on 07/22/2020 at the average price of $238.34. The price of the stock has decreased by 1.02% since.
- CEO John Oyler sold 55,175 shares of BGNE stock on 07/21/2020 at the average price of $251.84. The price of the stock has decreased by 6.33% since.
- CEO John Oyler sold 53,914 shares of BGNE stock on 07/08/2020 at the average price of $199.12. The price of the stock has increased by 18.47% since.
- CEO John Oyler sold 5,251 shares of BGNE stock on 07/01/2020 at the average price of $191.85. The price of the stock has increased by 22.96% since.
- CEO John Oyler sold 39,732 shares of BGNE stock on 06/24/2020 at the average price of $185.9. The price of the stock has increased by 26.9% since.
CFO Recent Trades:
- CFO & Chief Strategy Officer Howard Liang sold 300 shares of BGNE stock on 06/29/2020 at the average price of $191.23. The price of the stock has increased by 23.36% since.
Directors and Officers Recent Trades:
- President & GM China Xiaobin Wu sold 3,300 shares of BGNE stock on 07/20/2020 at the average price of $249.22. The price of the stock has decreased by 5.34% since.
- Chair, Scientific Advisory Brd Xiaodong Wang sold 17,000 shares of BGNE stock on 07/20/2020 at the average price of $251.51. The price of the stock has decreased by 6.21% since.
- President & GM China Xiaobin Wu sold 5,700 shares of BGNE stock on 07/15/2020 at the average price of $230. The price of the stock has increased by 2.57% since.
- Chair, Scientific Advisory Brd Xiaodong Wang sold 6,000 shares of BGNE stock on 07/07/2020 at the average price of $200. The price of the stock has increased by 17.95% since.
- CMO, Hematology Jane Huang sold 3,921 shares of BGNE stock on 07/07/2020 at the average price of $200. The price of the stock has increased by 17.95% since.
For the complete insider trading history of BGNE, click here
.
